Floatz logo

cp-751,871

Carcinoma, Adenosquamous

PfizerPhase 3Dormant
CCC
49/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
34/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Carcinoma, Adenosquamous cohort.

Asset / SponsorPhaseRating
Carboplatin
Pfizer
Phase 3B
e7 tcr-t cells
Christian Hinrichs
Phase 2B
Tsc-204-A0101
TScan Therapeutics, Inc.
Phase 1CC
Tsc-201-B0702
TScan Therapeutics, Inc.
Phase 1CC
Tsc-200-A0201
TScan Therapeutics, Inc.
Phase 1CC

View all 9 →

Same molecule, other indications

cp-751,871 is also rated in:

colorectal neoplasmDormant
CCC
Indicative ·
51 / 100
View asset →
non-small cell lung carcinomaDormant
CCC
Indicative ·
50 / 100
View asset →
prostate neoplasmDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →